Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience 14 May
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees 12 May
Bristol Myers Squibb Receives European Commission Approval of Sotyktu for the Treatment of Active Psoriatic Arthritis in Adults 08 May
